340 TGFβDNRII genetically-engineered TIL: characterizing final drug product from a phase I clinical trial
oleh: Yue Li, Chantale Bernatchez, Rodabe Amaria, Marie-Andree Forget, Priya Balasubramanian, Katrina Adlerz, Ellgar Jafari, Jane Zulovich, Donald Sakellariou-Thompson, Jason Bock
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.